11/26
02:06 pm
eq
Equillium (NASDAQ:EQ) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Equillium (NASDAQ:EQ) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
06:04 pm
eq
Equillium to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Equillium to Participate in Upcoming Investor Conferences [Yahoo! Finance]
11/20
04:35 pm
eq
Equillium to Participate in Upcoming Investor Conferences
Medium
Report
Equillium to Participate in Upcoming Investor Conferences
11/5
06:26 pm
eq
Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases Transcript [Seeking Alpha]
Low
Report
Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases Transcript [Seeking Alpha]
11/4
08:30 am
eq
Equillium to Participate in Upcoming Investor Conferences
Medium
Report
Equillium to Participate in Upcoming Investor Conferences
11/3
04:05 pm
eq
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/27
03:56 am
eq
Cipla's flagship respiratory initiative Breathefree broadens its footprint in the UAE
Low
Report
Cipla's flagship respiratory initiative Breathefree broadens its footprint in the UAE
10/22
08:00 am
eq
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
Medium
Report
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
10/6
04:23 pm
eq
Equillium Announces Leadership and Corporate Updates [Yahoo! Finance]
Low
Report
Equillium Announces Leadership and Corporate Updates [Yahoo! Finance]
10/6
04:02 pm
eq
Equillium Announces Leadership and Corporate Updates
Low
Report
Equillium Announces Leadership and Corporate Updates
10/3
03:35 pm
eq
Equillium (NASDAQ:EQ) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Equillium (NASDAQ:EQ) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
9/23
05:43 am
eq
NeuraClick Welcomes Biotech Veteran Daniel M. Bradbury as Strategic and Metabolic Programs Advisor [Yahoo! Finance]
Neutral
Report
NeuraClick Welcomes Biotech Veteran Daniel M. Bradbury as Strategic and Metabolic Programs Advisor [Yahoo! Finance]